LyondellBasell Industries
LYB
58.49
-0.44
-0.75%
LyondellBasell Industries
US · LYB
#972 by market cap
Listed 1970
58.49
-0.44
-0.75%
Live - 5344 symbols - heartbeat 228s ago
· 2026-10-08 07:08
Pre-market
59.25
+1.30%
After-hours
58.49
0.00%
Overnight
58.52
+0.05%
- Market cap
- 18.89B
- P/E (TTM)i
- -52.22
- P/Bi
- 1.77
- EPSi
- -2.34
- Div yieldi
- 7.04%
- 52W posi
- 45%
Reader sentiment
Are you bullish or bearish on LYB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 1.89, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -9.71% YoY
Margins
- Gross margin
- 8.55%
- Operating margin
- 2.76%
- Net margin
- -2.49%
Key ratios & quality
- Enterprise valuei
- 28.76B
- Altman Z-Scorei
- 1.89
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 39.00B | 34.73B | 27.75B | 46.17B | 50.45B | 33.34B | 33.39B | 30.15B |
| Gross profit | 6.48B | 5.43B | 3.39B | 8.78B | 6.60B | 4.90B | 4.64B | 2.58B |
| Selling & admin expenses | 1.13B | 1.20B | 1.14B | 1.26B | 1.31B | 1.54B | 1.64B | 1.61B |
| Research & development | 115.00M | 111.00M | 113.00M | 124.00M | 124.00M | 130.00M | 135.00M | 136.00M |
| Operating profit | 5.23B | 4.12B | 2.14B | 7.40B | 5.17B | 3.23B | 2.87B | 831.00M |
| Pretax profit | 5.31B | 4.05B | 1.39B | 6.79B | 4.78B | 2.30B | 1.70B | -715.00M |
| Tax | 613.00M | 648.00M | -43.00M | 1.16B | 882.00M | 433.00M | 259.00M | 70.00M |
| Net profit | 4.69B | 3.40B | 1.43B | 5.62B | 3.89B | 2.12B | 1.37B | -738.00M |
| Basic EPS | 12 | 10 | 4 | 17 | 12 | 6 | 4 | -2 |
| Diluted EPS | 12.01 | 9.58 | 4.24 | 16.75 | 11.81 | 6.46 | 4.15 | -2.34 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 7.68B | 7.66B | 7.73B | 7.09B | 7.20B | 9.18B |
| Gross profit | 549.00M | 787.00M | 906.00M | 335.00M | 701.00M | 2.04B |
| Selling & admin expenses | 401.00M | 435.00M | 401.00M | 373.00M | 411.00M | 387.00M |
| Research & development | 34.00M | 35.00M | 34.00M | 33.00M | 36.00M | 34.00M |
| Operating profit | 114.00M | 317.00M | 471.00M | -71.00M | 254.00M | 1.62B |
| Pretax profit | 59.00M | 224.00M | -856.00M | -142.00M | 137.00M | 808.00M |
| Tax | 36.00M | 69.00M | -27.00M | -8.00M | -2.00M | 236.00M |
| Net profit | 177.00M | 115.00M | -890.00M | -140.00M | 125.00M | 559.00M |
| Basic EPS | 1 | 0 | -3 | 0 | 0 | 2 |
| Diluted EPS | 0.54 | 0.34 | -2.77 | -0.45 | 0.38 | 1.71 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 10.57B | 9.51B | 11.63B | 12.22B | 11.85B | 13.15B | 12.27B | 10.87B |
| Cash & ST investments | 1.22B | 1.05B | 2.47B | 1.48B | 2.15B | 3.39B | 3.38B | 3.44B |
| Inventory | 4.52B | 4.59B | 4.34B | 4.90B | 4.80B | 4.77B | 4.66B | 3.53B |
| Total assets | 28.28B | 30.44B | 35.40B | 36.74B | 36.37B | 37.00B | 35.75B | 34.00B |
| Total current liabilities | 5.51B | 5.20B | 5.50B | 7.23B | 6.76B | 7.15B | 6.71B | 6.13B |
| Short-term debt | 890.00M | 721.00M | 981.00M | 704.00M | 1.13B | 1.26B | 972.00M | 1.18B |
| Long-term debt | 8.50B | 11.61B | 15.29B | 11.25B | 10.54B | 10.33B | 10.53B | 12.12B |
| Total liabilities | 17,882,000,000.00 | 22,256,000,000.00 | 27,299,000,000.00 | 24,754,000,000.00 | 23,622,000,000.00 | 23,942,000,000.00 | 23,158,000,000.00 | 23,796,000,000.00 |
| Total equity | 10.40B | 8.18B | 8.10B | 11.99B | 12.74B | 13.06B | 12.59B | 10.21B |
| Retained earnings | 6.76B | 4.44B | 4.44B | 8.56B | 9.20B | 9.69B | 9.33B | 6.81B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 11.40B | 11.08B | 10.76B | 10.87B | 11.06B | 11.67B |
| Cash & ST investments | 1.87B | 1.70B | 1.78B | 3.44B | 2.64B | 2.63B |
| Inventory | 4.93B | 4.57B | 4.41B | 3.53B | 3.64B | 4.08B |
| Total assets | 35.19B | 35.35B | 33.79B | 34.00B | 33.96B | 34.48B |
| Total current liabilities | 6.24B | 6.24B | 6.85B | 6.13B | 7.19B | 7.11B |
| Short-term debt | 615.00M | 614.00M | 1.22B | 1.18B | 1.69B | 1.70B |
| Long-term debt | 10.61B | 11.21B | 10.64B | 12.12B | 11.23B | 11.22B |
| Total liabilities | 22,854,000,000.00 | 23,317,000,000.00 | 23,063,000,000.00 | 23,796,000,000.00 | 23,793,000,000.00 | 23,688,000,000.00 |
| Total equity | 12.34B | 12.04B | 10.72B | 10.21B | 10.17B | 10.79B |
| Retained earnings | 9.06B | 8.73B | 7.40B | 6.81B | 6.71B | 7.04B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 5.47B | 4.96B | 3.40B | 7.70B | 6.12B | 4.94B | 3.82B | 2.26B |
| Depreciation & amortization | 1.24B | 1.31B | 1.39B | 1.39B | 1.27B | 1.53B | 1.52B | 1.39B |
| Free cash flow | 3.37B | 2.27B | 1.46B | 5.74B | 4.23B | 3.41B | 1.98B | 384.00M |
| Dividends paid | -1.55B | -1.46B | -1.41B | -1.49B | -3.25B | -1.61B | -1.72B | -1.76B |
| Stock buybacks / issuance | -1.85B | -3.75B | -4.00M | -463.00M | -420.00M | -211.00M | -195.00M | -201.00M |
| Ending cash balance | 401.00M | 888.00M | 1.77B | 1.48B | 2.16B | 3.41B | 3.39B | 3.45B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -579.00M | 351.00M | 983.00M | 1.51B | -269.00M | 752.00M |
| Depreciation & amortization | 323.00M | 332.00M | 350.00M | 385.00M | 342.00M | 347.00M |
| Free cash flow | -1.06B | -188.00M | 577.00M | 1.06B | -538.00M | 482.00M |
| Dividends paid | -433.00M | -445.00M | -443.00M | -443.00M | -224.00M | -224.00M |
| Stock buybacks / issuance | -110.00M | -91.00M | 0 | 0 | 0 | 0 |
| Ending cash balance | 1.87B | 1.70B | 1.80B | 3.45B | 2.64B | 2.64B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 48.76 | 36.98 | 17.70 | 56.44 | 31.64 | 16.50 | 10.66 | -6.67 |
| ROA %i | 17.19 | 11.53 | 4.30 | 15.51 | 10.59 | 5.74 | 3.72 | -2.16 |
| ROIC %i | 26.66 | 17.75 | 7.62 | 23.64 | 15.93 | 9.24 | 6.37 | -1.77 |
| 5-year avg ROE %i | 54.95 | 54.34 | 45.85 | 44.98 | 38.30 | 31.85 | 26.59 | 21.72 |
| EBIT margin %i | 14.54 | 12.67 | 6.89 | 15.82 | 10.04 | 7.55 | 5.17 | -0.76 |
| FCF / sales %i | 8.63 | 6.53 | 5.25 | 12.42 | 8.38 | 8.30 | 4.91 | 1.27 |
| Current ratioi | 1.92 | 1.83 | 2.11 | 1.69 | 1.75 | 1.84 | 1.83 | 1.77 |
| Quick ratioi | 1.03 | 0.87 | 1.26 | 0.93 | 0.92 | 1.03 | 1.03 | 1.02 |
| Debt / assetsi | 33.20 | 44.52 | 49.40 | 37.01 | 36.23 | 35.14 | 36.15 | 43.04 |
| LT debt / equityi | 82.84 | 159.50 | 207.10 | 108.75 | 95.52 | 90.81 | 95.90 | 133.42 |
| Interest coveragei | 15.75 | 12.68 | 3.63 | 14.08 | 17.64 | 6.51 | 4.33 | -0.47 |
| Revenue CAGR (3Y) %i | 6.01 | 5.97 | -6.98 | 5.79 | 13.26 | 6.30 | -10.24 | -15.77 |
| Net income CAGR (3Y) %i | 1.55 | -4.04 | -33.73 | 6.17 | 4.62 | 14.18 | -37.65 | -- |
| FCF CAGR (3Y) %i | -8.56 | -12.32 | -26.43 | 19.44 | 23.10 | 32.78 | -29.85 | -55.05 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 8.39 | 1.96 | -9.98 | -6.67 | -7.21 | -3.19 |
| ROA %i | 2.94 | 0.69 | -3.41 | -2.16 | -2.32 | -1.03 |
| ROIC %i | 5.28 | 2.01 | -3.58 | -1.77 | -2.24 | -0.39 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.98 | 1.56 | -2.69 | -0.76 | -0.40 | 1.55 |
| FCF / sales %i | 3.82 | 1.20 | 1.95 | 1.27 | 3.06 | 5.06 |
| Current ratioi | 1.83 | 1.77 | 1.57 | 1.77 | 1.54 | 1.64 |
| Quick ratioi | 0.91 | 0.79 | 0.70 | 1.02 | 0.82 | 0.93 |
| Debt / assetsi | 35.99 | 37.43 | 39.12 | 43.04 | 41.97 | 41.24 |
| LT debt / equityi | 98.69 | 105.95 | 113.22 | 133.42 | 125.09 | 117.37 |
| Interest coveragei | 3.43 | 1.31 | -2.16 | -0.47 | -0.23 | 0.90 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Olefins and Polyolefins-Americas (O&P-Americas) is the largest reported line at 38.37% of revenue, across 6 reported segments.
- No single line clears half of revenue; Olefins and Polyolefins-Europe, Asia, International (O&P-EAI) is next at 32.20%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Olefins and Polyolefins-Americas (O&P-Americas)38.37%
Olefins and Polyolefins-Europe, Asia, International (O&P-EAI)32.20%
Intermediates and Derivatives (I&D)29.93%
Advanced Polymer Solutions (APS)11.01%
Technology1.82%
Quote time 2026-10-08 07:08:23 · For reference only, not investment advice and not tailored to your situation.